Robert A. Weinberg

Robert Weinberg is one of the most influential cancer biologists of the twentieth and twenty-first centuries. A founding member of the Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research at MIT, he has spent more than four decades elucidating the fundamental molecular logic of cancer initiation, progression, and metastasis. In 1979, Weinberg's laboratory isolated the first human oncogene — a mutant form of the RAS gene derived from a human bladder carcinoma cell line. This landmark discovery demonstrated that human cancers arise from mutated versions of normal cellular genes and established the oncogene paradigm that defines modern cancer molecular biology. His group subsequently identified the first tumor suppressor gene, RB1 (retinoblastoma protein), demonstrating the opposing class of cancer-driving alterations. Weinberg's most broadly influential contribution is the "Hallmarks of Cancer" conceptual framework, co-authored with Douglas Hanahan and published in Cell in 2000 (and updated in 2011 and 2022). This synthesis organized the bewildering diversity of cancer phenotypes into a coherent set of acquired biological capabilities — sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis induction, and invasion/metastasis activation — providing a unifying conceptual map for the entire field. In the twenty-first century, Weinberg's laboratory has focused extensively on the epithelial-mesenchymal transition (EMT), the developmental program co-opted by cancer cells to acquire invasive and metastatic properties. His work revealed how EMT transcription factors (SNAI1, ZEB1, TWIST) enable cancer cells to disseminate from primary tumors, survive in circulation, colonize distant organs, and acquire stem cell-like properties. He also discovered that cancer cells can occupy partial or hybrid EMT states with distinct biological behaviors, significantly expanding understanding of metastatic heterogeneity. Weinberg has trained generations of leading cancer researchers and is the author of the definitive textbook "The Biology of Cancer." He is a member of the National Academy of Sciences and recipient of virtually every major prize in cancer biology.

Robert Weinberg 是二十及二十一世纪最具影响力的癌症生物学家之一。作为怀特黑德生物医学研究所的创始成员和麻省理工学院丹尼尔·K·路德维格癌症研究教授，他用四十余年时间阐明了癌症发生、进展和转移的基本分子逻辑。 1979年，Weinberg 实验室分离出第一个人类癌基因——来源于人类膀胱癌细胞系的RAS基因突变体。这一里程碑式的发现证明了人类癌症由正常细胞基因的突变形式引发，确立了现代癌症分子生物学的癌基因范式。他的团队随后鉴定出第一个肿瘤抑制基因RB1（视网膜母细胞瘤蛋白）。 Weinberg 最广为人知的贡献是与 Douglas Hanahan 共同撰写的"癌症标志"概念框架（2000年发表于《细胞》杂志，2011年和2022年更新）。这一综述将令人眼花缭乱的癌症表型组织成一套连贯的获得性生物学能力，为整个领域提供了统一的概念地图。 在二十一世纪，他的实验室广泛聚焦于上皮-间充质转化（EMT），这一发育程序被癌细胞劫持以获得侵袭和转移特性，显著拓展了对转移异质性的理解。